UK markets open in 5 hours 48 minutes

CASI Pharmaceuticals, Inc. (CASI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.0900-0.1200 (-3.74%)
At close: 04:00PM EDT
3.1900 +0.10 (+3.24%)
After hours: 07:22PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-30,457
-26,938
-41,014
-36,654
-48,287
-
Depreciation & amortisation
-
3,741
2,422
1,815
1,959
-
Stock-based compensation
-
7,217
7,010
7,770
7,821
-
Change in working capital
-
-7,818
-6,650
-3,218
-3,318
-
Accounts receivable
-
3,422
-3,170
-5,158
-3,352
-
Inventory
-
-9,739
-4,231
-551
3,186
-
Accounts payable
-
1,149
1,066
1,491
-1,540
-
Other working capital
-
-22,208
-26,700
-42,342
-45,213
-
Other non-cash items
-
-
1,189
6,555
17,828
6,968
Net cash provided by operating activities
-
-19,967
-21,088
-26,842
-25,886
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-2,241
-5,612
-15,500
-19,327
-
Purchases of investments
-
-51,754
-7,425
0
-6,318
-
Sales/maturities of investments
-
44,322
37,622
0
0
-
Other investing activities
-
-
6,436
-5,201
2,226
-
Net cash used for investing activities
-
-9,673
31,159
-20,691
-20,719
-
Cash flows from financing activities
Debt repayment
-
0
-4,001
-1,548
0
-
Common stock issued
-
0
0
32,500
45,099
-
Common stock repurchased
-
-278
-3,267
0
-
-
Other financing activities
-
-738
-
-2,019
-2,818
19,601
Net cash used provided by (used for) financing activities
-
-907
-3,267
29,642
47,153
-
Net change in cash
-
-30,029
8,408
-18,360
3,443
-
Cash at beginning of period
-
47,112
38,704
57,064
53,621
-
Cash at end of period
-
17,083
47,112
38,704
57,064
-
Free cash flow
Operating cash flow
-
-19,967
-21,088
-26,842
-25,886
-
Capital expenditure
-
-2,241
-5,612
-15,500
-19,327
-
Free cash flow
-
-22,208
-26,700
-42,342
-45,213
-